Back to search

Germany· DE-A57-eac29f360a53f3bc

Amoxicillin/Clavulansäure Centrient

A medicinal product containing amoxicillin, clavulanic acid, registered in Germany by Centrient Pharmaceuticals Netherlands Bv.

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedAmoxicillin/Clavulansäure CentrientATC—REGISTER NO.DE-A57-eac29f360a53f3…PACKS LISTED0CHECKEDSeptember 30, 2026

The record

At a glance

EMA Article 57 (European Union)
Active substance
Amoxicillin, Clavulanic Acid
Manufacturer
Centrient Pharmaceuticals Netherlands Bv
Country
Germany (DE)
ATC code
—
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Amoxicillin, clavulanic acid in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All amoxicillin, clavulanic acid products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Amcladoz, Amclavu
  • Belgium · Amoclane, Amoclaneeg
  • Bulgaria · Amoksiklav Es, Aмоксигамма
  • Cyprus · Augmentin, Augmentin Es
  • Czechia · Amoksiklav, Amoxicillin/Clavulanic Acid Aptapharma
  • Denmark · Amoxicillin/Clavulansyre Aurobindo, Baxumil
  • Estonia · Amoksiklav, Amoxicillin/Clavulanic Acid Auxilia
  • Spain · Amoxicilina / Ácido Clavulánico Pensa Pharma, Amoxicilina/Ácido Clavulánico Almus
  • Finland · Amorion Comp, Amoxicillin/Clavulanic Acid Bioglan
  • France · Amoxicillin / Clavulanic Acid Reig Jofre, Amoxicillin/Acide Clavulanique Zydus France
  • United Kingdom (Northern Ireland) · Augmentin, Augmentin Duo
  • Greece · Augmentin, Augmentin Mf (Γεύση Φρούτων)
  • Croatia · Amoksicilin/Klavulanska Kiselina Antibiotice, Amoksicilin/Klavulanska Kiselina Aptapharma
  • Hungary · Aksolin, Aktil
  • Ireland · Amoclav, Amoxicillin/Clavulanic Acid Krka
  • Iceland · Amoxicillin/Clavulanic Acid Normon, Spectracillin
  • Italy · Abba, Abioclav
  • Lithuania · Amoksiklav, Amoxicillin/Clavulanic Acid Antibiotice
  • Luxembourg · Amoclane, Amoxiclav
  • Latvia · Amoksiklav, Amoxicillin/Clavulanic Acid
  • Malta · Amoxi-Clavulan, Amoxicillin/Clavulanic Acid Aptapharma
  • Netherlands · Amoxicillin/Clavulanic Acid Aurobindo, Amoxicilline/Clavulaanzuur
  • Norway · Augmentin, Augmentin Blandet Fruktsmak
  • Poland · Amoclan, Amoksiklav
  • Portugal · Agmalife, Agmalife Bid
  • Romania · Amoksiklav, Amoksiklav Quicktab
  • Sweden · Amoxicillin/Clavulanic Acid Aurobindo, Amoxicillin/Clavulanic Acid Bb
  • Slovenia · Amoksicilin/Klavulanska Kislina Antibiotice, Amoksicilin/Klavulanska Kislina Aptapharma
  • Slovakia · Amoksiklav, Amoksiklav 2 X

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ed70aeb3-26af-4c15-802e-302c28afee5b
GET /v1/drugs/ed70aeb3-26af-4c15-802e-302c28afee5b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Amoxicillin, Clavulanic Acid",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about amoxicillin, clavulanic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.